SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-035823
Filing Date
2019-06-17
Accepted
2019-06-17 08:36:22
Documents
6
Period of Report
2019-06-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-11481_18k.htm 8-K 63772
2 EX-2.1 a19-11481_1ex2d1.htm EX-2.1 657269
3 EX-3.1 a19-11481_1ex3d1.htm EX-3.1 5352
4 EX-99.1 a19-11481_1ex99d1.htm EX-99.1 49099
5 GRAPHIC g114811mmi001.jpg GRAPHIC 3847
6 GRAPHIC g114811mmi002.jpg GRAPHIC 3781
  Complete submission text file 0001104659-19-035823.txt   787656
Mailing Address 3200 WALNUT STREET BOULDER CO 80301
Business Address 3200 WALNUT STREET BOULDER CO 80301 3033816600
ARRAY BIOPHARMA INC (Filer) CIK: 0001100412 (see all company filings)

IRS No.: 841460811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-16633 | Film No.: 19900525
SIC: 2834 Pharmaceutical Preparations